Trial of the Week: Linezolid v Daptomycin in VRE BSI
Nick Britt joins to highlight his first author research comparing antibiotics for the treatment of vancoymycin-resistant Enterococcus bloodstream infections.
Pharmacy to Dose: The Critical Care Podcast
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Trial of the Week: Linezolid v Daptomycin in VRE BSI
Special Guest: Nick Britt, PharmD, MS, BCPS, BCIDP
Nick Britt joins to highlight his first-author research comparing the use of linezolid v. daptomycin for treatment of vancomycin-resistant Enterococcus bloodstream infection (VRE BSI) published in Clinical Infectious Diseases in 2015. We review what the standard of care was for treatment at this time, how this study became to be, covering this featured article and discussing outcomes/results, then reviewing studies published since, how we still use results from this study, and much, much more.
Reference list: https://pharmacytodose.files.wordpress.com/2023/09/dapto-v-linez-vre-bsi-references.pdf
PharmacyToDose.Com
@PharmacyToDose
Learn more about your ad choices. Visit megaphone.fm/adchoices